WESTLAKE CHEMICAL CORP 4
4 · WESTLAKE CHEMICAL CORP · Filed Aug 5, 2013
Insider Transaction Report
Form 4
Wallace Stephen
VP, General Counsel, Secretary
Transactions
- Exercise/Conversion
Common Stock
2013-08-01$20.52/sh+8,935$183,391→ 34,098 total - Exercise/Conversion
Employee Option (right to buy)
2013-08-01−8,935→ 0 totalExercise: $20.52From: 2013-02-26Exp: 2020-02-26→ Common Stock (8,935 underlying) - Exercise/Conversion
Employee Option (right to buy)
2013-08-01−1,261→ 0 totalExercise: $60.10From: 2013-02-17Exp: 2022-02-17→ Common Stock (1,261 underlying) - Exercise/Conversion
Common Stock
2013-08-01$45.83/sh+2,590$118,700→ 37,949 total - Exercise/Conversion
Common Stock
2013-08-01$60.10/sh+1,261$75,792→ 35,359 total - Sale
Common Stock
2013-08-01$105.71/sh−12,786$1,351,671→ 25,163 total - Exercise/Conversion
Employee Option (right to buy)
2013-08-01−2,590→ 0 totalExercise: $45.83From: 2013-02-18Exp: 2021-02-18→ Common Stock (2,590 underlying)
Holdings
- 200(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]In accordance with the Securities and Exchange Commission's No Action Letter dated June 25, 2008, we have aggregated the sales that occurred on August 1, 2013 for ease of reporting. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $105.6000 to $105.9050, inclusive. The reporting person undertakes to provide to Westlake Chemical Corp., any security holder of Westlake Chemical Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.